Your cornea is slowly changing shape and glasses can no longer keep up. Keratoconus is progressive, but with early diagnosis and the right treatment most people keep excellent functional vision for life.
Keratoconus is a condition in which the cornea, the clear dome-shaped front surface of the eye, gradually thins and steepens into a cone-like shape instead of its normal smooth curve. This progressive change causes vision to become increasingly distorted and blurred in ways that glasses cannot fully correct. It typically begins in the teenage years or early twenties and progresses at a variable rate over the following one to two decades before often stabilizing. It affects around 1 in 500 people and is one of the most common reasons for corneal transplantation in developed countries, though modern treatments have cut how often surgery is needed.
What You Need to Know About Keratoconus
- Keratoconus causes the cornea to progressively thin and bulge forward, distorting vision in ways glasses cannot fully correct Specialist management is provided by the cornea and refractive surgery subspecialty.
- It typically begins in the teens or early twenties and progresses over years before stabilizing, usually in the mid-thirties
- Corneal cross-linking halts progression by stiffening the corneal tissue. It doesn’t reverse existing changes but prevents further deterioration
- Most people with keratoconus achieve good functional vision with specialist contact lenses, particularly scleral lenses
- Corneal transplantation is now needed in only around 10 to 20 percent of cases
- Rubbing the eyes vigorously is strongly associated with progression and must be avoided
What Happens to the Cornea
In a healthy eye, the cornea has a smooth, regular curvature that bends incoming light precisely onto the retina. In keratoconus, the structural collagen that gives the cornea its strength gradually weakens in a localised area, usually in the lower central cornea. Without adequate structural support, the cornea bows outward under normal intraocular pressure, creating a progressively steeper, irregular cone shape.
This irregular surface scatters light rather than focusing it cleanly. Vision becomes blurry and distorted, with ghost images and multiple copies of a single point of light. Glasses help early on but progressively fail to correct the increasingly irregular surface. Patients often describe a cycle of prescription changes, one after another, without ever quite getting to clear. That pattern — never satisfied with new glasses — is one of the things that makes an optometrist think of keratoconus.
Diagnosis
Corneal topography
Corneal topography is the key diagnostic tool. It produces a colour-coded map of the corneal surface curvature. Normal corneas show a relatively symmetrical pattern. Keratoconus produces a characteristic asymmetric inferior hot spot or skewed bow-tie pattern that is immediately recognisable to an experienced examiner.
Corneal tomography (such as the Pentacam) adds three-dimensional analysis including thickness maps and posterior surface elevation. Thin areas and posterior surface changes can be detected before the condition is visible on topography alone. This matters for identifying subclinical keratoconus before refractive surgery is considered, and for staging the condition accurately.
When to suspect keratoconus
Keratoconus is often suspected when a young patient presents with rapidly changing glasses prescriptions, poor best-corrected visual acuity, or a complaint that vision is blurry and distorted even with new glasses. A history of vigorous eye rubbing, dry eye, or blepharitis causing chronic irritation and rubbing raises suspicion. A family history is present in around 10 percent of cases. Worth asking about. Associations with atopic disease (eczema, hay fever, asthma) are well established.
Stages of Keratoconus
Early keratoconus
Mild corneal steepening and early topographic changes with relatively good best-corrected visual acuity. Spectacles may still provide reasonable correction. The cornea is not badly thinned. This is the optimal stage for cross-linking if progression is documented, as the cornea has the most tissue available and the best structural foundation for treatment.
Progressive keratoconus
Increasing irregular astigmatism makes spectacle correction inadequate. Rigid or scleral contact lenses are needed for functional vision. Corneal thinning is measurable. Fleischer ring and Vogt’s striae may be visible on slit lamp examination. Cross-linking remains effective at this stage.
Advanced keratoconus
Significant corneal thinning and pronounced cone shape. The apex may show scarring from repeated minor trauma to the thin epithelium. Corneal hydrops, where fluid suddenly enters the cornea through a break in Descemet’s membrane, can cause sudden severe vision loss and pain, leaving a scar. Cross-linking may still be possible if corneal thickness permits.
End-stage keratoconus
Severe thinning, significant scarring, and a cornea too irregular and compromised for contact lens wear or cross-linking. At this stage, corneal transplantation is considered. Deep anterior lamellar keratoplasty (DALK) replaces the front layers while preserving the patient’s own endothelium. Outcomes from corneal transplantation for keratoconus are among the best of any indication for the procedure.
Treatment
Corneal cross-linking
Corneal collagen cross-linking (CXL) is the only treatment that halts or slows progression. Riboflavin drops are applied to the cornea, followed by controlled ultraviolet A light, creating new chemical bonds between collagen fibrils that stiffen and strengthen the tissue. It doesn’t reverse existing changes or directly improve vision, but it prevents further deterioration. Most effective when performed early, before significant thinning and scarring occur. Accelerated protocols have reduced treatment time to around 10 to 30 minutes in the clinic.
Contact lenses: correcting vision
Contact lenses are the primary means of achieving good functional vision in keratoconus once spectacles become inadequate. The lens vaults over the irregular corneal surface and replaces it with a smooth regular refracting interface, dramatically improving visual quality that would otherwise be impossible to achieve with glasses.
Rigid gas-permeable (RGP) lenses are supplemented or increasingly replaced by scleral lenses, which are large-diameter rigid lenses resting on the sclera rather than the cornea. Scleral lenses vault completely over the cone, are more comfortable than corneal RGPs, and provide excellent optics. They are the preferred option for moderate to advanced keratoconus in most specialist centres. Hybrid lenses and piggyback systems are alternatives for patients who struggle with scleral lens handling.
Corneal implants and transplantation
Intrastromal corneal ring segments (ICRS) are small curved plastic inserts placed within the corneal stroma to flatten and regularise the surface. They can improve topographic regularity enough to allow better contact lens fitting and sometimes improve best-corrected acuity. When the cornea is too scarred or thin for cross-linking and contact lens wear is no longer viable, corneal transplantation is considered. DALK is preferred over full-thickness penetrating keratoplasty for keratoconus, with consistently high success rates and long graft survival.
The Single Most Important Thing You Can Do: Stop Rubbing Your Eyes
Eye rubbing is strongly and consistently associated with keratoconus onset and progression. The mechanical trauma from vigorous rubbing damages the corneal collagen and is thought to be one of the primary drivers in genetically susceptible individuals. Many patients with keratoconus have a history of allergic eye disease, blepharitis, or dry eye causing chronic itching. Treating the underlying cause of the itch is therefore part of treating the keratoconus itself.
If your eyes itch, the right response is a cold compress, antihistamine drops, or artificial tears. Not rubbing. If blepharitis or dry eye is causing chronic irritation, treating it actively reduces the impulse to rub and directly reduces one of the most modifiable risk factors for progression.
And this applies equally after cross-linking. The structural strengthening achieved by CXL can be undermined by continued vigorous rubbing, and documented cases of progression after cross-linking are disproportionately associated with persistent eye rubbing. Not rubbing your eyes is as important as any clinical treatment you receive.
Seek Urgent Review If You Notice
- Sudden severe pain in one eye with a dramatic worsening of vision, particularly if the eye appears cloudy
- A rapid unexplained change in your contact lens fit or vision that differs from your usual gradual progression
- Significant worsening on repeat corneal topography compared to your previous map
- Any young patient with rapidly changing prescription and poor best-corrected acuity not yet investigated for keratoconus
Sudden corneal hydrops causes acute pain, photophobia, and dramatic vision loss in advanced keratoconus. It resolves over weeks to months but often leaves a scar. If you have keratoconus and experience sudden eye pain with significant vision loss, contact your corneal unit the same day.
Frequently Asked Questions About Keratoconus
-
Will keratoconus make me blind?
Rarely, if ever. What it causes is progressive reduction in corrected visual acuity as the cornea becomes more irregular, to the point where glasses can’t correct vision adequately. With specialist contact lenses, most people with even moderate to advanced keratoconus achieve functional vision that allows driving, working, and living normally. In the small proportion who reach end-stage disease, corneal transplantation restores good vision in the majority. The outlook for most people with keratoconus is genuinely positive with appropriate management.
-
Will cross-linking improve my vision?
Cross-linking is not primarily a vision-improving treatment. Its purpose is to halt progression. Most patients see no significant change in their topography or corrected visual acuity from CXL itself. The benefit is measured over years: a cornea that hasn’t progressed five years after cross-linking is a success, even if vision is unchanged from before the procedure.
-
Can I have laser eye surgery if I have keratoconus?
Absolutely not. Standard laser surgery removes corneal tissue, which further weakens an already compromised cornea. In a keratoconic eye, this can trigger rapid, catastrophic progression. Any patient being considered for laser refractive surgery should have corneal topography and tomography to exclude keratoconus beforehand. This is one of the most important pre-surgical screening steps in refractive surgery practice.
-
Is keratoconus hereditary?
There is a hereditary component in around 10 percent of cases. If you have keratoconus, it is reasonable to have first-degree relatives screened with corneal topography, particularly children and teenagers. Early detection allows cross-linking to be performed before significant visual impact occurs. Most cases appear without a clear family history. But the increased risk in first-degree relatives is real enough to warrant screening.
-
How long does cross-linking last?
Long-term studies show stable or improved topography at 10 years and beyond after treatment in the majority of patients. A small proportion, particularly younger patients with more aggressive progression at the time of treatment, may show some continued slow progression and require re-treatment. Annual topography monitoring continues after CXL rather than stopping once treatment is complete, for exactly this reason.
-
Can I drive with keratoconus?
Many people with keratoconus drive successfully, particularly with well-fitted specialist contact lenses that correct their vision to the legal standard. Patients whose vision with best correction doesn’t meet the legal standard should not drive and should inform their licensing authority. If contact lenses restore vision to the required level, driving is permitted while wearing them. Discuss your specific situation with your ophthalmologist if you’re unsure.
If you would like to learn more, the American Academy of Ophthalmology’s keratoconus page offers a clear overview of symptoms, causes, diagnosis, and treatment options.
Keratoconus (KCN) is a progressive, non-inflammatory corneal ectasia characterized by progressive thinning and conical protrusion of the cornea, leading to irregular myopic astigmatism and reduced BCVA that cannot be corrected with spectacles in advanced cases. It typically presents in the second decade of life and progresses through the second and third decades before stabilizing in most patients. Bilateral disease is the rule, though asymmetry is common and the timing of fellow-eye involvement is unpredictable. The prevalence is approximately 1 in 2,000 in the general population, rising to 1 in 500 in some Middle Eastern and South Asian populations. Contact lens fitting and corneal collagen cross-linking (CXL) are the mainstays of management; corneal transplantation is reserved for contact-lens intolerant advanced disease.
Clinical Overview: Keratoconus
- Diagnosis: Requires OCT and corneal topography , Placido-disk or Scheimpflug (Pentacam) imaging. Keratometry above 47.2 D (measured on slit-lamp or topographer), irregular astigmatism, inferior-superior (I-S) asymmetry, posterior elevation above reference sphere, and Belin-Ambrosio D-score above 1.6 (Pentacam) are diagnostic criteria. Slit-lamp: Vogt’s striae, Fleischer ring, Munson’s sign (advanced)
- Amsler-Krumeich grading: Stage I: Kmax <48 D, mild changes. Stage II: Kmax 48-53 D, no corneal scarring. Stage III: Kmax 53-55 D, no scarring. Stage IV: Kmax >55 D or BCVA ≤6/60, or scarring present
- Progression indicators (treat with CXL): Kmax increase >1 D over 12 months, increase in manifest refraction astigmatism >1 D, decrease in thinnest corneal point >2%, BCVA loss of ≥1 line, posterior elevation increase >2 µm. In patients under 18: lower threshold , treat even mild progression.
- CXL (corneal collagen cross-linking): Dresden protocol , epithelium off, 0.1% riboflavin drops for 30 min, 3 mW/cm² UV-A for 30 min (5.4 J/cm²). Accelerated CXL: higher irradiance, shorter time, equivalent total energy. Halts progression in ~90% of eyes. Does not significantly reverse existing ectasia. Minimum corneal thickness 400 µm required (standard protocol).
- Vision correction: Spectacles (early), soft toric contact lenses (early), rigid gas-permeable (RGP) lenses (moderate), scleral lenses (advanced), hybrid lenses. INTACS intrastromal ring segments: improve contact lens tolerance and flatten the cornea modestly. Topography-guided PRK+CXL: selected cases.
- Surgery: DALK (deep anterior lamellar keratoplasty) preferred over PK in keratoconus without scarring , preserves the patient’s own Descemet’s membrane and endothelium, lower rejection risk, equivalent visual outcomes to PK in experienced hands.
Pathophysiology and Risk Factors
Keratoconus results from a combination of genetic predisposition and environmental triggers causing degradation of corneal stromal collagen. The corneal stroma , 90% of corneal thickness, composed of collagen lamellae , loses its structural integrity through increased proteolytic enzyme activity (MMPs, cathepsins), reduced anti-protease activity (alpha-1 antitrypsin, alpha-2 macroglobulin), and oxidative stress-mediated keratocyte apoptosis. As the stroma thins and weakens, IOP and biomechanical forces progressively deform the cornea into a cone, producing the characteristic irregular astigmatism.
Eye rubbing , the most modifiable risk factor: Chronic vigorous eye rubbing is strongly associated with keratoconus onset and progression. The mechanical trauma produces cytokine release (IL-6, IL-13), collagen fibril disorganization, and keratocyte apoptosis. The mechanism explains why keratoconus is more common in patients with atopic disease (who rub their eyes frequently), blepharitis, and vernal keratoconjunctivitis. Eye rubbing cessation counseling is a non-negotiable part of every keratoconus consultation.
Genetic factors: KCN is polygenic with variable penetrance. First-degree relatives have a lifetime risk approximately 15-20 times higher than the general population. Multiple susceptibility loci identified (VSX1, DOCK9, ZEB1, among others). The observation that keratoconus is more common in patients with Down syndrome (trisomy 21) implicates chromosome 21 loci.
Diagnosis
Anterior segment OCT and corneal topography and tomography: Corneal topography (Placido disk, color-coded anterior curvature map) identifies the typical inferior steepening and asymmetric bowtie pattern. Corneal tomography (Scheimpflug , Pentacam, Galilei) provides anterior and posterior elevation maps, pachymetry (corneal thickness) map, and the Belin-Ambrosio D (BAD-D) score combining these parameters into a single ectasia risk score. BAD-D above 1.6 is highly sensitive and specific for keratoconus. The thinnest corneal point location and value are key treatment planning parameters.
Slit-lamp signs: Vogt’s striae , vertical fine stress lines in the posterior stroma visible with retroillumination, disappearing with digital pressure on the globe. Fleischer ring , iron deposition in the basal epithelium at the base of the cone, forming a partial or complete ring, best seen with cobalt blue light. Munson’s sign , V-shaped deformation of the lower lid on downgaze (advanced). Rizzuti’s sign , conical reflection on the nasal cornea when a penlight is directed from the temporal side (advanced). Corneal scarring at the cone apex indicates Bowman’s layer breaks from hydrops or chronic ectasia.
Acute Hydrops
Acute corneal hydrops is a sudden complication of keratoconus in which a break in Descemet’s membrane allows aqueous humor to flood into the corneal stroma, producing sudden, severe corneal edema, pain, photophobia, and markedly reduced vision. It typically occurs in eyes with advanced keratoconus and a history of vigorous eye rubbing. The majority of hydrops episodes resolve spontaneously over 8-12 weeks as the break in Descemet’s membrane heals. During resolution, a scar forms at the hydrops site , which, paradoxically, can reduce the corneal ectasia by creating a flat, scarred area at the cone apex.
Management: hypertonic saline drops (5% NaCl) to draw fluid from the stroma, a bandage contact lens for comfort, and topical antibiotics to prevent secondary infection. Intrastromal gas injection (intrastromal C3F8) accelerates resolution and is used in severe or prolonged hydrops at specialist centers. Urgent corneal transplantation is not indicated during active hydrops , wait for resolution before planning surgery.
CXL: Indications, Technique, and Outcomes
Patient selection for CXL: Documented progression over 12 months by any standard parameter (Kmax, refraction, pachymetry, BCVA) plus minimum corneal thickness at thinnest point 400 µm (standard Dresden protocol) or 350 µm (modified protocols). In patients under 18, a lower threshold for treatment is appropriate given the more aggressive progression trajectory in younger patients. In subclinical keratoconus (forme fruste): evidence for prophylactic CXL is growing but not yet uniform guideline-standard; discuss with patient regarding the progression risk from eye rubbing.
Procedure: Epithelial debridement (8-9 mm zone), riboflavin 0.1% drops every 2-3 minutes for 30 minutes to saturate the stroma. UV-A (365 nm, 3 mW/cm² for 30 minutes, total dose 5.4 J/cm²) , the Dresden protocol. Accelerated protocols (9, 18, or 30 mW/cm² for proportionally shorter times) achieve equivalent total energy but have slightly lower efficacy data in some series. Epi-on (transepithelial CXL) preserves the epithelium but has lower riboflavin penetration and lower reported success rates in most published series , not the standard of care.
Expected outcomes: Approximately 90% of eyes treated with the Dresden protocol show no further topographic or refractive progression at 3-5 years. Kmax may decrease modestly (1-2 D mean) in the first 12 months post-CXL. BCVA sometimes improves slightly from reduced irregular astigmatism as the cornea reshapes during cross-linking-induced remodeling. Full refractive stabilization takes 12-18 months , do not change spectacle or contact lens prescriptions during this period.
Contact Lens Fitting in Keratoconus
Progressive contact lens approach: Soft toric lenses (early Stage I-II, mild irregular astigmatism). RGP (rigid gas-permeable) lenses: the workhorse for moderate keratoconus. The rigid lens vaults over the cone apex and creates a regular tear lens front surface, neutralizing the irregular astigmatism. Fitting requires keratoconus-specific lens designs (e.g., Rose K, ClearKone). Scleral lenses (large diameter, 15-18 mm, resting on the sclera): the best option for advanced keratoconus, severe irregular astigmatism, contact-lens intolerant eyes, or post-CXL eyes with residual irregular astigmatism. The fluid reservoir between lens and cornea provides excellent visual rehabilitation and comfort even on scarred or irregular surfaces.
Clinical Decision Points
- Keratoconus, stable for 3 years, Kmax 47 D, BCVA 6/9 with RGP lens: No CXL indication. Continue annual topography surveillance. Reinforce eye rubbing cessation. Monitor for late progression at times of ocular allergy or atopic flares.
- Keratoconus, age 16, Kmax 50 D, progression of 1.5 D in 6 months: Offer CXL promptly. In patients under 18, earlier treatment limits cumulative ectasia. Check corneal thickness before scheduling.
- Post-CXL, 18 months, Kmax plateau, still needing RGP lens for adequate BCVA: CXL does not improve contact lens tolerance or VA directly. Discuss INTACS if cone is eccentric and causing contact lens fitting problems, or topography-guided PRK+CXL (the “Athens protocol”) to flatten the cone and improve spectacle-corrected VA before scleral lens fitting.
- Corneal thickness 350 µm, symptomatic progression: Standard Dresden CXL is relatively contraindicated. Consider modified epi-on CXL, accelerated protocols, or corneal transplantation planning if the ectasia is Stage III-IV.
- Acute hydrops: Hypertonic NaCl drops, bandage contact lens, topical antibiotic. Do not attempt CXL during active hydrops. Reassess for transplantation after full resolution (8-12 weeks minimum).
When to Expedite Assessment
- Sudden severe corneal edema with pain and markedly reduced vision in a keratoconus patient , acute hydrops, requires same-day assessment
- New corneal infiltrate in a contact lens-wearing keratoconus patient , presumed microbial keratitis, emergency assessment and scraping for culture
- Rapid Kmax progression above 2 D in 6 months or BCVA loss of more than 2 lines , expedite CXL assessment
Microbial keratitis is significantly more common in contact lens-wearing keratoconus patients than in the general contact lens-wearing population, partly because keratoconus patients tend to overwear their lenses (driven by the vision requirement), and partly because an irregular corneal surface is harder to fit without micro-trauma at the lens edge. A keratoconus patient presenting with a painful red eye and reduced vision should be treated as a contact-lens-related microbial keratitis emergency until proven otherwise.
Clinical Pearls: Keratoconus
-
Eye rubbing cessation is the single most important behavioral modification you can give a keratoconus patient. It needs emphasis every visit.
The evidence linking eye rubbing to keratoconus onset and progression is strong , retrospective series consistently show high prevalence of chronic eye rubbing (70-90% of keratoconus patients vs 20-30% of controls). The mechanism is mechanical: corneal deformation from rubbing exceeds physiological IOP-induced stress and triggers proteolytic remodeling. Most patients are aware of rubbing but underestimate its frequency and force. Atopic disease management (antihistamines, mast cell stabilizers, allergen avoidance) to reduce the itch that drives rubbing is as clinically important as any surgical planning decision in progressing keratoconus.
-
The subclinical (forme fruste) fellow eye in asymmetric keratoconus needs close surveillance, not dismissal.
It is common to find one eye with obvious keratoconus and a fellow eye with borderline topographic changes , slight inferior steepening, asymmetric bow-tie, BAD-D 1.2-1.5. This is not a normal eye. It is a subclinical keratoconus eye at significant risk of progression, particularly if the patient continues eye rubbing. It needs annual topography, not discharge. The refractive surgeon who performs LASIK on this eye , because the topography is “borderline” , risks inducing post-LASIK ectasia: one of the most legally and clinically consequential errors in anterior segment surgery.
-
Scleral lenses transform the lives of advanced keratoconus patients. Refer earlier than you think.
Many patients with advanced keratoconus who struggle with RGP lens fitting or who have been told they are “running out of options” before transplantation have never been fitted with a scleral lens. Scleral lenses routinely achieve BCVA of 6/6-6/9 in eyes where spectacles give 6/60 and RGP lenses are intolerable, by creating a smooth fluid-filled optical system that bypasses the irregular corneal surface entirely. A referral to a specialist contact lens practitioner experienced in scleral lens fitting should happen before corneal transplantation is discussed with the patient.
Further reading: RCOphth Keratoconus Guidelines. For related ocular surface conditions see dry eye disease (commonly co-existing) and blepharitis (allergic eye disease drives rubbing). The full corneal context is on the cornea and refractive surgery subspecialty page.